{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T09:03:49Z","timestamp":1771232629302,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T00:00:00Z","timestamp":1523923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1245\/s10434-018-6481-y","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T14:31:31Z","timestamp":1523975491000},"page":"1953-1960","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Biopsy Feasibility Trial for Breast Cancer Pathologic Complete Response Detection after Neoadjuvant Chemotherapy: Imaging Assessment and Correlation Endpoints"],"prefix":"10.1245","volume":"25","author":[{"given":"Gaiane M.","family":"Rauch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry M.","family":"Kuerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Adrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lumarie","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Moseley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalind P.","family":"Candelaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa","family":"Arribas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica W. T.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savitri","family":"Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei T.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,17]]},"reference":[{"key":"6481_CR1","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1200\/JCO.2014.55.2836","volume":"32","author":"A Berruti","year":"2014","unstructured":"Berruti A, Amoroso V, Gallo F, et al. Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studies. J Clin Oncol. 2014;32:3883\u201391.","journal-title":"J Clin Oncol."},{"key":"6481_CR2","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1016\/j.ejca.2012.05.023","volume":"48","author":"N Houssami","year":"2012","unstructured":"Houssami N, Macaskill P, von Minckwitz G, Marinovich ML, Mamounas E. Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy. Eur J Cancer. 2012;48:3342\u201354.","journal-title":"Eur J Cancer"},{"key":"6481_CR3","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","volume":"30","author":"G Minckwitz von","year":"2012","unstructured":"von Minckwitz G, Untch M, Blohmer JU, et al. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol. 2012;30:1796\u2013804.","journal-title":"J Clin Oncol."},{"key":"6481_CR4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","volume":"384","author":"P Cortazar","year":"2014","unstructured":"Cortazar P, Zhang L, Untch M, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014;384:164\u201372.","journal-title":"Lancet."},{"key":"6481_CR5","doi-asserted-by":"publisher","first-page":"290","DOI":"10.2214\/AJR.16.17223","volume":"208","author":"GM Rauch","year":"2017","unstructured":"Rauch GM, Adrada BE, Kuerer HM, van la Parra RF, Leung JW, Yang WT. Multimodality imaging for evaluating response to neoadjuvant chemotherapy in breast cancer. Am J Roentgenol. 2017;208:290\u20139.","journal-title":"Am J Roentgenol."},{"key":"6481_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/01.sla.0000197714.14318.6f","volume":"243","author":"AB Chagpar","year":"2006","unstructured":"Chagpar AB, Middleton LP, Sahin AA, et al. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg. 2006;243:257\u201364.","journal-title":"Ann Surg."},{"key":"6481_CR7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.amjsurg.2009.03.012","volume":"199","author":"JD Keune","year":"2010","unstructured":"Keune JD, Jeffe DB, Schootman M, Hoffman A, Gillanders WE, Aft RL. Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer. Am J Surg. 2010;199:477\u201384.","journal-title":"Am J Surg."},{"key":"6481_CR8","doi-asserted-by":"publisher","first-page":"260","DOI":"10.2214\/AJR.09.3908","volume":"195","author":"Y Yuan","year":"2010","unstructured":"Yuan Y, Chen XS, Liu SY, Shen KW. Accuracy of MRI in prediction of pathologic complete remission in breast cancer after preoperative therapy: a meta-analysis. Am J Roentgenol. 2010;195:260\u20138.","journal-title":"Am J Roentgenol."},{"key":"6481_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/jnci\/djs528","volume":"105","author":"ML Marinovich","year":"2013","unstructured":"Marinovich ML, Houssami N, Macaskill P, et al. Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy. J Natl Cancer Inst. 2013;105:321\u201333.","journal-title":"J Natl Cancer Inst."},{"key":"6481_CR10","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1148\/radiol.12110748","volume":"263","author":"NM Hylton","year":"2012","unstructured":"Hylton NM, Blume JD, Bernreuter WK, et al. Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy\u2014results from ACRIN 6657\/I-SPY trial. Radiology. 2012;263:663\u201372.","journal-title":"Radiology."},{"key":"6481_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002313","author":"HM Kuerer","year":"2017","unstructured":"Kuerer HM, Rauch GM, Krishnamurthy S, et al. A clinical feasibility trial for identification of exceptional responders in whom breast cancer surgery can be eliminated following neoadjuvant systemic therapy. Ann Surg. 2017. \n                    https:\/\/doi.org\/10.1097\/SLA.0000000000002313\n                    \n                  .","journal-title":"Ann Surg."},{"key":"6481_CR12","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/bjc.2015.381","volume":"113","author":"J Heil","year":"2015","unstructured":"Heil J, Kummel S, Schaefgen B, et al. Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques. Br J Cancer. 2015;113:1565\u201370.","journal-title":"Br J Cancer."},{"key":"6481_CR13","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-017-5926-z","author":"HM Kuerer","year":"2017","unstructured":"Kuerer HM, Vrancken Peeters M, Rea DW, Basik M, De Los Santos J, Heil J. Nonoperative management for invasive breast cancer after neoadjuvant systemic therapy: conceptual basis and fundamental international feasibility clinical trials. Ann Surg Oncol. 2017. \n                    https:\/\/doi.org\/10.1245\/s10434-017-5926-z\n                    \n                  .","journal-title":"Ann Surg Oncol."},{"key":"6481_CR14","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1245\/s10434-006-9086-9","volume":"13","author":"F Peintinger","year":"2006","unstructured":"Peintinger F, Kuerer HM, Anderson K, et al. Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy. Ann Surg Oncol. 2006;13:1443\u20139.","journal-title":"Ann Surg Oncol."},{"key":"6481_CR15","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1245\/s10434-014-4113-8","volume":"22","author":"BE Adrada","year":"2015","unstructured":"Adrada BE, Huo L, Lane DL, Arribas EM, Resetkova E, Yang W. Histopathologic correlation of residual mammographic microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer. Ann Surg Oncol. 2015;22:1111\u20137.","journal-title":"Ann Surg Oncol."},{"key":"6481_CR16","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1245\/s10434-015-4993-2","volume":"23","author":"YS Kim","year":"2016","unstructured":"Kim YS, Chang JM, Moon HG, Lee J, Shin SU, Moon WK. Residual mammographic microcalcifications and enhancing lesions on MRI after neoadjuvant systemic chemotherapy for locally advanced breast cancer: correlation with histopathologic residual tumor size. Ann Surg Oncol. 2016;23:1135\u201342.","journal-title":"Ann Surg Oncol."},{"key":"6481_CR17","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1245\/s10434-016-5741-y","volume":"24","author":"Y Feliciano","year":"2017","unstructured":"Feliciano Y, Mamtani A, Morrow M, Stempel MM, Patil S, Jochelson MS. Do calcifications seen on mammography after neoadjuvant chemotherapy for breast cancer always need to be excised? Ann Surg Oncol. 2017; 24:1492\u20138.","journal-title":"Ann Surg Oncol."},{"key":"6481_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13058-016-0684-6","volume":"18","author":"RF Parra van la","year":"2016","unstructured":"van la Parra RF, Kuerer HM. Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials. Breast Cancer Res. 2016;18:28.","journal-title":"Breast Cancer Res."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-018-6481-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6481-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6481-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T23:10:17Z","timestamp":1555456217000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-018-6481-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,17]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["6481"],"URL":"https:\/\/doi.org\/10.1245\/s10434-018-6481-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,17]]},"assertion":[{"value":"19 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}